iBio and Planet Biotechnology entered into exclusive worldwide license agreement for development of a COVID-19 therapeutic
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
-
-
Moderna confirmed discussions with the MHLW to supply Japan with 40 million doses of mRNA vaccine against COVID-19
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
-
NCI and Cancer Research UK launched Cancer Grand Challenges partnership to support bold new ideas for cancer research
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
-
RedHill Biopharma Announced Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
-
NIH established Centers for Research in Emerging Infectious Diseases
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
-
AIM ImmunoTech decreased SARS-CoV-2 infectious viral yields by 90% using new in vitro model
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
-
Todos Medical announced $4,500,000 contract for COVID-19 PCR testing equipment & supplies with New York-based laboratory
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
-
Vaccitech received government grant for COVID-19 vaccine research
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
-
Biotechnology | COVID-19 | Diagnostics | NIH
White House announced plan to deploy 150 million rapid tests in 2020
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
-
Laurent Pharmaceuticals received FDA approval to initiate its COVID-19 phase 2 clinical trial in the U.S.
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
-
International research alliance launched to boost pandemic preparedness
On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
-
Assembly Biosciences and Arbutus announced collaboration to evaluate combination of core inhibitor ABI-H0731 with RNAi Therapeutic AB-729 in patients with Chronic Hepatitis B Virus Infection
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
-
BioNTech and Fosun Pharma to potentially supply 10 Million doses of BNT162 mRNA-based vaccine candidate against SARS-CoV-2
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
-
Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
-
VBI Vaccines announced preclinical Coronavirus program data and selection of clinical candidates with potential one-dose vaccines
On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
-
UConn received federal funding to develop self-administered microneedle COVID-19 vaccine technology
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
-
National Science Foundation advanced artificial intelligence research with new nationwide institutes
On Aug. 26, 2020, the National Science Foundation (NSF) announced that it was establishing new artificial intelligence institutes…
-
Rapid diagnostic detected Lassa and Ebola in real-time
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
-
Journal of American College of Cardiology published pioneering study using Stereotaxis robotic technology to treat pulmonary hypertension
On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of…
-
Altimmune and University of Alabama announced potent respiratory mucosal T cell responses in peclinical study of intranasal COVID-19 vaccine candidate
On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
-
Abbott’s fast, $5, 15-minute, easy-to-use COVID-19 antigen test for healthcare professionals received FDA Emergency Use Authorization
On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWﾙ COVID-19…
-
Heat Biologics’ announced publication of preclinical COVID-19 vaccine results
On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…
-
How SARS-CoV-2 spread across greater Boston during pandemic’s first wave
On Aug. 25, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, the Massachusetts…
-
CytoDyn reached enrollment of 195 patients in its phase 3 trial for COVID-19 patients with severe-to-critical symptoms
On Aug. 25, 2020, CytoDyn announced the Company had reached the requisite number of enrolled patients in its…
-
Momentous milestone as Africa announced eradication of wild Poliovirus
On Aug. 25, 2020, the independent Africa Regional Certification Commission (ARCC) for Polio Eradication officially declared that the…
-
Sinovac signed agreement with Bio Farma Indonesia for COVID-19 vaccine cooperation
On Aug. 25, 2020, Sinovac Biotech announced it had signed two agreements in Hainan, China with PT Bio…
-
Codex DNA building worldﾒs first vaccine printer and global vaccine network
On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterﾙ (DBC) platform….
-
Intravacc and Therapyx jointly developed the world’s first prophylactic gonorrhea vaccine
On Aug. 25, 2020, Intravacc announced that it had partnered with American, Buffalo, NY, based Therapyx, to further…
-
Phase I clinical trial initiated for monoclonal antibody combination for the prevention and treatment of COVID-19
On Aug. 25, 2020, AstraZeneca announced that the first participants have been dosed in a Phase I trial…
-
NantKwest and ImmunityBio inked an agreement for joint development, manufacturing, marketing, and commercialization of COVID-19 vaccine
On Aug. 24 2020, NantKwest and ImmunityBio announced an agreement to jointly develop, manufacture, market, and commercialize therapeutics…
